Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
2151
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.48M | ﹤0.01% |
+252,100
| New | +$1.33M |
|
2152
China Automotive Systems
CAAS
$142M
| $1.47M | ﹤0.01% |
456,094
+23,990
| +6% | +$82.4K |
|
2153
Allogene Therapeutics
ALLO
$708M
| $1.47M | ﹤0.01% |
458,648
+428,366
| +1,415% | +$1.21M |
|
2154
Riley Exploration Permian
REPX
$800M
| $1.47M | ﹤0.01% |
53,900
+30,989
| +135% | +$875K |
|
2155
Custom Truck One Source
CTOS
$2.4B
| $1.47M | ﹤0.01% |
237,300
+18,900
| +9% | +$111K |
|
2156
Ivanhoe Electric
IE
$1.66B
| $1.47M | ﹤0.01% |
+145,400
| New | +$1.54M |
|
|
CIVI
2157
DELISTED
Civitas Resources
CIVI
| $1.46M | ﹤0.01% |
+21,407
| New | +$1.53M |
|
2158
Portillo's
PTLO
$374M
| $1.46M | ﹤0.01% |
91,900
-173,200
| -65% | -$2.68M |
|
2159
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $1.46M | ﹤0.01% |
56,738
-2,420
| -4% | -$67.2K |
|
2160
US Physical Therapy
USPH
$1.21B
| $1.46M | ﹤0.01% |
15,649
-26,304
| -63% | -$2.32M |
|
|
AAMI
2161
Acadian Asset Management
AAMI
$3.28B
| $1.45M | ﹤0.01% |
75,800
-42,200
| -36% | -$746K |
|
2162
Adicet Bio
ACET
$78.4M
| $1.45M | ﹤0.01% |
47,913
+5,600
| +13% | +$122K |
|
2163
DigitalOcean
DOCN
$15.3B
| $1.45M | ﹤0.01% |
+39,500
| New | +$1.09M |
|
2164
Landmark Bancorp
LARK
$196M
| $1.45M | ﹤0.01% |
80,608
-569
| -0.7% | -$9.3K |
|
2165
RUM Group Inc
RUM
$3.7B
| $1.45M | ﹤0.01% |
321,759
+238,159
| +285% | +$1.16M |
|
2166
Transcat
TRNS
$877M
| $1.44M | ﹤0.01% |
13,200
+7,499
| +132% | +$721K |
|
2167
Alta Equipment Group
ALTG
$237M
| $1.44M | ﹤0.01% |
116,400
-52,788
| -31% | -$570K |
|
2168
Babcock & Wilcox
BW
$1.53B
| $1.44M | ﹤0.01% |
985,475
+734,037
| +292% | +$1.56M |
|
2169
Riverview Bancorp
RVSB
$106M
| $1.44M | ﹤0.01% |
224,607
+8,000
| +4% | +$47K |
|
2170
SEACOR Marine Holdings
SMHI
$268M
| $1.44M | ﹤0.01% |
114,100
+12,900
| +13% | +$165K |
|
|
CDTX
2171
DELISTED
Cidara Therapeutics
CDTX
| $1.43M | ﹤0.01% |
90,109
+10,125
| +13% | +$163K |
|
2172
Norwood Financial Corp
NWFL
$376M
| $1.43M | ﹤0.01% |
43,475
-800
| -2% | -$22.5K |
|
|
TCN
2173
DELISTED
Tricon Residential Inc.
TCN
| $1.43M | ﹤0.01% |
+157,300
| New | +$1.21M |
|
2174
Oak Valley Bancorp
OVLY
$287M
| $1.43M | ﹤0.01% |
47,673
-456
| -0.9% | -$11.9K |
|
2175
Diebold Nixdorf
DBD
$2.48B
| $1.42M | ﹤0.01% |
+49,000
| New | +$1.12M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.